References
- Global Burden of Disease Cancer CollaborationFitzmauriceCAllenCGlobal, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease studyJAMA Oncol20173452454827918777
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- HerbstRSHeymachJVLippmanSMLung cancerN Engl J Med2008359131367138018815398
- ReckMPopatSReinmuthNMetastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-upAnn Oncol201425Suppl 3iii27iii3925115305
- ThakurMKWozniakAJSpotlight on necitumumab in the treatment of non-small-cell lung carcinomaLung Cancer20178131928293124
- BaylinSBEstellerMRountreeMRBachmanKESchuebelKHermanJGAberrant patterns of DNA methylation, chromatin formation and gene expression in cancerHum Mol Genet200110768769211257100
- BaylinSBHermanJGGraffJRVertinoPMIssaJPAlterations in DNA methylation: a fundamental aspect of neoplasiaAdv Cancer Res1998721411969338076
- DeissLPKimchiAA genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signalScience199125250021171201901424
- KimchiADAP genes: novel apoptotic genes isolated by a functional approach to gene cloningBiochim Biophys Acta199813772F13F339606974
- DeissLPFeinsteinEBerissiHCohenOKimchiAIdentification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell deathGenes Dev19959115307828849
- GozuacikDKimchiADAPk protein family and cancerAutophagy200622747917139808
- KögelDReimertzCDüssmannHMechPScheidtmannKHPrehnJHThe death associated protein (DAP) kinase homologue Dlk/ZIP kinase induces p19ARF- and p53-independent apoptosisEur J Cancer200339224925612509958
- InbalBBialikSSabanayIShaniGKimchiADAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell deathJ Cell Biol2002157345546811980920
- PattingreSTassaAQuXBcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagyCell2005122692793916179260
- KissilJLFeinsteinECohenODAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor geneOncogene19971544034079242376
- LehmannUCelikkayaGHasemeierBLängerFKreipeHPromoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtypeCancer Res200262226634663812438260
- LévyDPlu-BureauGDecroixYDeath-associated protein kinase loss of expression is a new marker for breast cancer prognosisClin Cancer Res20041093124313015131053
- KimDHNelsonHHWienckeJKPromoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancerOncogene200120141765177011313923
- LuCSoriaJCTangXPrognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markersJ Clin Oncol200422224575458315542809
- TangXKhuriFRLeeJJHypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancerJ Natl Cancer Inst200092181511151610995806
- BainsMSSurgical treatment of lung cancerChest199110038268371889280
- BuckinghamLPenfield FaberLKimAPTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patientsInt J Cancer201012671630163919795445
- FengQHawesSESternJEDNA methylation in tumor and matched normal tissues from non-small cell lung cancer patientsCancer Epidemiol Biomarkers Prev200817364565418349282
- GuoHZhouSTanLWuXWuZRanRClinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature reviewOncotarget2017822550255727911280
- JinGKimMJJeonHSPTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancersLung Cancer201069327928320018398
- TammemagiMCMclaughlinJRBullSBMeta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancersCancer Epidemiol Biomarkers Prev19998762563410428201
- Cancer Genome Atlas Research NetworkComprehensive genomic characterization of squamous cell lung cancersNature2012489741751952522960745
- AliAKumarSKakariaVKDetection of promoter DNA methylation of APC, DAPK, and GSTP1 genes in tissue biopsy and matched serum of advanced-stage lung cancer patientsCancer Invest201735642343028524770
- JinYXuPLiuXCigarette smoking, BPDE-DNA adducts, and aberrant promoter methylations of tumor suppressor genes (TSGs) in NSCLC from Chinese populationCancer Invest201634417318027042875
- GuoMAlumkalJDrachovaTCHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancerDiscov Med20151910415115825828518
- KonticMStojsicJJovanovicDAberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinomaClin Lung Cancer201213429730322169480
- FujiiMFujimotoNHirakiAAberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaCancer Sci2012103351051422146010
- ZhangCYJinYTXuHYRelationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancerZhonghua Yi Xue Yi Chuan Xue Za Zhi2011281232821287504
- ZhangYWangRSongHMethylation of multiple genes as a candidate biomarker in non-small cell lung cancerCancer Lett20113031212821255913
- JinYXuHZhangCCombined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in ChinaBMC Cancer20101042220704749
- PengZShanCWangHValue of promoter methylation of RASSF1A, p16, and DAPK genes in induced sputum in diagnosing lung cancersZhong Nan Da Xue Xue Bao Yi Xue Ban201035324725320360646
- NiklinskaWNaumnikWSulewskaAKozłowskiMPankiewiczWMilewskiRPrognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC)Folia Histochem Cytobiol200947227528019926549
- HanWWangTReillyAAKellerSMSpivackSDGene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patientsRespir Res2009108619781081
- LicchesiJDWestraWHHookerCMHermanJGPromoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lungClin Cancer Res20081492570257818451218
- KatayamaHHirakiAFujiwaraKAberrant promoter methylation profile in pleural fluid DNA and clinicopathological factors in patients with non-small cell lung cancerAsian Pac J Cancer Prev20078222122417696735
- YanagawaNTamuraGOizumiHPromoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancersLung Cancer200758113113817606310
- LiuYGaoWSiegfriedJMWeissfeldJLLuketichJDKeohavongPPromoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokersBMC Cancer200777417477876
- BelinskySAGrimesMJCasasEPredicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serumBr J Cancer20079681278128317406356
- FischerJROhnmachtURiegerNPrognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabineLung Cancer200756111512317196704
- KimYTParkSJLeeSHPrognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lungJ Thorac Cardiovasc Surg200513051378137816256792
- de FraipontFMoro-SibilotDMichellandSBrambillaEBrambillaCFavrotMCPromoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?Lung Cancer200550219920916043258
- SafarAMSpencerHSuXMethylation profiling of archived non-small cell lung cancer: a promising prognostic systemClin Cancer Res200511124400440515958624
- RussoALThiagalingamAPanHDifferential DNA hyper-methylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancerClin Cancer Res20051172466247015814621
- KimYTLeeSHSungSWKimJHCan aberrant promoter hyper-methylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?Ann Thorac Surg200579411801188 discussion 1180–118815797047
- FujiwaraKFujimotoNTabataMIdentification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancerClin Cancer Res20051131219122515709192
- DivineKKPullingLCMarron-TeradaPGMultiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokersInt J Cancer2005114340040515578700
- ToyookaSToyookaKOMiyajimaKEpigenetic down-regulation of death-associated protein kinase in lung cancersClin Cancer Res2003983034304112912953
- SoriaJCRodriguezMLiuDDLeeJJHongWKMaoLAberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokersCancer Res200262235135511809677
- Zöchbauer-MüllerSFongKMVirmaniAKGeradtsJGazdarAFMinnaJDAberrant promoter methylation of multiple genes in non-small cell lung cancersCancer Res200161124925511196170